Compare Stocks

Date Range: 

 The OLB GroupPacific West BankSilverSun TechnologiesLogiqProtagenic Therapeutics
SymbolNASDAQ:OLBOTCMKTS:PWBONASDAQ:SSNTOTCMKTS:WEYLOTCMKTS:PTIX
Price Information
Current Price$5.46$16.00$9.00$3.25$2.16
50-Day Moving Average$5.57$15.65$9.37$2.97$2.61
52-Week Low$3.26$9.56$2.20$1.62$1.05
52-Week High$16.40$18.00$14.87$10.50$7.00
MarketRank™
Overall Score1.90.01.51.01.2
Analysis Score3.50.00.00.00.0
Community Score5.00.04.05.04.4
Dividend Score0.00.00.00.00.0
Ownership Score0.80.03.30.01.7
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AN/A
Consensus Price Target$9.00N/AN/AN/AN/A
% Upside from Price Target64.84% upsideN/AN/AN/AN/A
Trade Information
Market Cap$38.85 million$42.45 million$45.55 million$43.27 million$31.63 million
BetaN/A0.131.091.43-0.52
Average Volume358,59065392,99223,703338,917
Sales & Book Value
Annual Revenue$9.77 millionN/A$41.22 million$34.65 millionN/A
Price / Sales3.97N/A1.101.25N/A
CashflowN/AN/A$0.29 per shareN/AN/A
Price / CashN/AN/A31.22N/AN/A
Book Value$0.93 per shareN/A$1.62 per share$1.22 per share($0.11) per share
Price / Book5.87N/A5.562.66N/A
Profitability
Net Income$-1,780,000.00N/A$180,000.00$-6,540,000.00$-2,550,000.00
EPSN/AN/AN/AN/AN/A
Trailing P/E RatioN/A0.000.00N/AN/A
Forward P/E Ratio
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-24.90%N/A1.96%-21.55%N/A
Return on Equity (ROE)-26.48%N/A9.06%-59.07%N/A
Return on Assets (ROA)-17.20%N/A4.72%-50.00%-398.88%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%N/A0.05%0.02%N/A
Current Ratio6.32%N/A1.93%3.38%0.30%
Quick Ratio6.32%N/A1.93%3.38%0.30%
Ownership Information
Institutional Ownership Percentage1.92%15.85%9.53%N/AN/A
Insider Ownership PercentageN/AN/A44.94%9.50%45.00%
Miscellaneous
Employees24N/A16517N/A
Shares Outstanding7.11 million2.65 million5.06 million13.31 million14.64 million
Next Earnings Date8/16/2021 (Estimated)N/A8/11/2021 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
Protagenic Therapeutics (OTCMKTS:PTIX) Stock Passes Above Two Hundred Day Moving Average of $0.00Protagenic Therapeutics (OTCMKTS:PTIX) Stock Passes Above Two Hundred Day Moving Average of $0.00
americanbankingnews.com - July 27 at 2:44 AM
Protagenic Therapeutics Updates on Patient Enrollment for PT00114 Trial, Shares LowerProtagenic Therapeutics Updates on Patient Enrollment for PT00114 Trial, Shares Lower
marketwatch.com - July 23 at 7:33 PM
Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 ...Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 ...
apnews.com - July 23 at 7:33 PM
Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical TrialProtagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial
finance.yahoo.com - July 23 at 7:33 PM
Digital Media Solutions (NYSE:DMS) versus Protagenic Therapeutics (OTCMKTS:PTIX) Critical ComparisonDigital Media Solutions (NYSE:DMS) versus Protagenic Therapeutics (OTCMKTS:PTIX) Critical Comparison
americanbankingnews.com - July 19 at 1:22 AM
Head to Head Contrast: Quhuo (NASDAQ:QH) versus Protagenic Therapeutics (OTCMKTS:PTIX)Head to Head Contrast: Quhuo (NASDAQ:QH) versus Protagenic Therapeutics (OTCMKTS:PTIX)
americanbankingnews.com - July 13 at 6:12 PM
Protagenic Therapeutics (OTCMKTS:PTIX) Shares Cross Above 200 Day Moving Average of $0.00Protagenic Therapeutics (OTCMKTS:PTIX) Shares Cross Above 200 Day Moving Average of $0.00
americanbankingnews.com - July 10 at 1:30 AM
Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10 00 AM ETProtagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10 00 AM ET
wallstreet-online.de - July 6 at 11:20 PM
Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ETProtagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET
finance.yahoo.com - July 6 at 8:05 AM
Selling Your CoProtagenic Therapeutics Inc. (NASDAQ: PTIX) mpany Stock? Here’s What You Need To KnowSelling Your CoProtagenic Therapeutics Inc. (NASDAQ: PTIX) mpany Stock? Here’s What You Need To Know
stocksregister.com - July 1 at 8:56 AM
Protagenic Therapeutics Inc. (NASDAQ:PTIX) – Analysts See The Stock Differently TodayProtagenic Therapeutics Inc. (NASDAQ:PTIX) – Analysts See The Stock Differently Today
marketingsentinel.com - June 30 at 7:13 AM
What Could Change After Protagenic Therapeutics Inc. (NASDAQ: PTIX) Gains 66.24% From The High-Point?What Could Change After Protagenic Therapeutics Inc. (NASDAQ: PTIX) Gains 66.24% From The High-Point?
marketingsentinel.com - June 25 at 9:39 AM
The Next Few Weeks Are A Good Time To Consider Protagenic Therapeutics Inc. (PTIX)The Next Few Weeks Are A Good Time To Consider Protagenic Therapeutics Inc. (PTIX)
stocksregister.com - June 24 at 8:26 AM
Is Protagenic Therapeutics Inc. (NASDAQ: PTIX) Dead In The Water?Is Protagenic Therapeutics Inc. (NASDAQ: PTIX) Dead In The Water?
stocksregister.com - June 21 at 9:09 AM
Top Moving Stock Now – Protagenic Therapeutics Inc. (NASDAQ: PTIX)Top Moving Stock Now – Protagenic Therapeutics Inc. (NASDAQ: PTIX)
stocksregister.com - June 16 at 10:04 AM
Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17thProtagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
finance.yahoo.com - June 16 at 10:04 AM
Protagenic Therapeutics Inc. Shares Are Down -82.66% Since The Beginning Of The YearProtagenic Therapeutics Inc. Shares Are Down -82.66% Since The Beginning Of The Year
marketingsentinel.com - June 15 at 8:33 AM
Protagenic Therapeutics Inc. [PTIX] is 182.86% higher this YTD. Is it still time to buy?Protagenic Therapeutics Inc. [PTIX] is 182.86% higher this YTD. Is it still time to buy?
dbtnews.com - June 14 at 7:01 PM
Protagenic Therapeutics Inc.Protagenic Therapeutics Inc.
barrons.com - June 13 at 2:06 PM
Protagenic Therapeutics Inc. (NASDAQ: PTIX) Stock Seems Like A Good OptionProtagenic Therapeutics Inc. (NASDAQ: PTIX) Stock Seems Like A Good Option
stocksregister.com - June 11 at 3:45 PM
What Should You Do With Protagenic Therapeutics Inc. (NASDAQ: PTIX) At Current Prices?What Should You Do With Protagenic Therapeutics Inc. (NASDAQ: PTIX) At Current Prices?
marketingsentinel.com - June 11 at 10:45 AM
Protagenic Therapeutics Inc. [PTIX] is 156.19% higher this YTD. Is it still time to buy?Protagenic Therapeutics Inc. [PTIX] is 156.19% higher this YTD. Is it still time to buy?
dbtnews.com - May 27 at 5:43 AM
How is the Protagenic Therapeutics, Inc. (NASDAQ:PTIX) performance outlook for the coming months?How is the Protagenic Therapeutics, Inc. (NASDAQ:PTIX) performance outlook for the coming months?
marketingsentinel.com - May 26 at 10:17 AM
What Will Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Be Like After It Drops -126.39% From Its Highs?What Will Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Be Like After It Drops -126.39% From Its Highs?
marketingsentinel.com - May 22 at 10:56 AM
Protagenic Therapeutics Inc. [PTIX] is 108.57% higher this YTD. Is it still time to buy?Protagenic Therapeutics Inc. [PTIX] is 108.57% higher this YTD. Is it still time to buy?
dbtnews.com - May 17 at 10:07 PM
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.